Global Long-acting Injectable Medications Market Growth (Status and Outlook) 2025-2031

September 2025 | 104 pages | ID: G4CD526C6075EN
LP Information

Abstracts

According to this study, the global Long-acting Injectable Medications market size will reach US$ million by 2031.

Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdoses. Its origins in indications such as schizophrenia and contraception, also HIV treatment and prevention.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Long-acting Injectable Medications Industry Forecast” looks at past sales and reviews total world Long-acting Injectable Medications sales in 2024, providing a comprehensive analysis by region and market sector of projected Long-acting Injectable Medications sales for 2025 through 2031. With Long-acting Injectable Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting Injectable Medications industry.

This Insight Report provides a comprehensive analysis of the global Long-acting Injectable Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long-acting Injectable Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting Injectable Medications market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting Injectable Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting Injectable Medications.

This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting Injectable Medications market by product type, application, key players and key regions and countries.

Segmentation by Type:

• First-generation
• Second-generation

Segmentation by Application:

• Schizophrenia
• Contraception
• HIV
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Eli Lilly
• Alkermes
• Johnson & Johnson
• Zogenix
• DURECT
• Mapi Pharma
• GSK
• MedinCell
• Oakwood Labs
• Nanomi
• Pharmathen
• Kashiv BioSciences

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Long-acting Injectable Medications Market Size (2020-2031)
  2.1.2 Long-acting Injectable Medications Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Long-acting Injectable Medications by Country/Region (2020, 2024 & 2031)
2.2 Long-acting Injectable Medications Segment by Type
  2.2.1 First-generation
  2.2.2 Second-generation
2.3 Long-acting Injectable Medications Market Size by Type
  2.3.1 Long-acting Injectable Medications Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Long-acting Injectable Medications Market Size Market Share by Type (2020-2025)
2.4 Long-acting Injectable Medications Segment by Application
  2.4.1 Schizophrenia
  2.4.2 Contraception
  2.4.3 HIV
  2.4.4 Others
2.5 Long-acting Injectable Medications Market Size by Application
  2.5.1 Long-acting Injectable Medications Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Long-acting Injectable Medications Market Size Market Share by Application (2020-2025)

3 LONG-ACTING INJECTABLE MEDICATIONS MARKET SIZE BY PLAYER

3.1 Long-acting Injectable Medications Market Size Market Share by Player
  3.1.1 Global Long-acting Injectable Medications Revenue by Player (2020-2025)
  3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Player (2020-2025)
3.2 Global Long-acting Injectable Medications Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LONG-ACTING INJECTABLE MEDICATIONS BY REGION

4.1 Long-acting Injectable Medications Market Size by Region (2020-2025)
4.2 Global Long-acting Injectable Medications Annual Revenue by Country/Region (2020-2025)
4.3 Americas Long-acting Injectable Medications Market Size Growth (2020-2025)
4.4 APAC Long-acting Injectable Medications Market Size Growth (2020-2025)
4.5 Europe Long-acting Injectable Medications Market Size Growth (2020-2025)
4.6 Middle East & Africa Long-acting Injectable Medications Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Long-acting Injectable Medications Market Size by Country (2020-2025)
5.2 Americas Long-acting Injectable Medications Market Size by Type (2020-2025)
5.3 Americas Long-acting Injectable Medications Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Long-acting Injectable Medications Market Size by Region (2020-2025)
6.2 APAC Long-acting Injectable Medications Market Size by Type (2020-2025)
6.3 APAC Long-acting Injectable Medications Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Long-acting Injectable Medications Market Size by Country (2020-2025)
7.2 Europe Long-acting Injectable Medications Market Size by Type (2020-2025)
7.3 Europe Long-acting Injectable Medications Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Long-acting Injectable Medications by Region (2020-2025)
8.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2020-2025)
8.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LONG-ACTING INJECTABLE MEDICATIONS MARKET FORECAST

10.1 Global Long-acting Injectable Medications Forecast by Region (2026-2031)
  10.1.1 Global Long-acting Injectable Medications Forecast by Region (2026-2031)
  10.1.2 Americas Long-acting Injectable Medications Forecast
  10.1.3 APAC Long-acting Injectable Medications Forecast
  10.1.4 Europe Long-acting Injectable Medications Forecast
  10.1.5 Middle East & Africa Long-acting Injectable Medications Forecast
10.2 Americas Long-acting Injectable Medications Forecast by Country (2026-2031)
  10.2.1 United States Market Long-acting Injectable Medications Forecast
  10.2.2 Canada Market Long-acting Injectable Medications Forecast
  10.2.3 Mexico Market Long-acting Injectable Medications Forecast
  10.2.4 Brazil Market Long-acting Injectable Medications Forecast
10.3 APAC Long-acting Injectable Medications Forecast by Region (2026-2031)
  10.3.1 China Long-acting Injectable Medications Market Forecast
  10.3.2 Japan Market Long-acting Injectable Medications Forecast
  10.3.3 Korea Market Long-acting Injectable Medications Forecast
  10.3.4 Southeast Asia Market Long-acting Injectable Medications Forecast
  10.3.5 India Market Long-acting Injectable Medications Forecast
  10.3.6 Australia Market Long-acting Injectable Medications Forecast
10.4 Europe Long-acting Injectable Medications Forecast by Country (2026-2031)
  10.4.1 Germany Market Long-acting Injectable Medications Forecast
  10.4.2 France Market Long-acting Injectable Medications Forecast
  10.4.3 UK Market Long-acting Injectable Medications Forecast
  10.4.4 Italy Market Long-acting Injectable Medications Forecast
  10.4.5 Russia Market Long-acting Injectable Medications Forecast
10.5 Middle East & Africa Long-acting Injectable Medications Forecast by Region (2026-2031)
  10.5.1 Egypt Market Long-acting Injectable Medications Forecast
  10.5.2 South Africa Market Long-acting Injectable Medications Forecast
  10.5.3 Israel Market Long-acting Injectable Medications Forecast
  10.5.4 Turkey Market Long-acting Injectable Medications Forecast
10.6 Global Long-acting Injectable Medications Forecast by Type (2026-2031)
10.7 Global Long-acting Injectable Medications Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Long-acting Injectable Medications Forecast

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly
  11.1.1 Eli Lilly Company Information
  11.1.2 Eli Lilly Long-acting Injectable Medications Product Offered
  11.1.3 Eli Lilly Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Eli Lilly Main Business Overview
  11.1.5 Eli Lilly Latest Developments
11.2 Alkermes
  11.2.1 Alkermes Company Information
  11.2.2 Alkermes Long-acting Injectable Medications Product Offered
  11.2.3 Alkermes Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Alkermes Main Business Overview
  11.2.5 Alkermes Latest Developments
11.3 Johnson & Johnson
  11.3.1 Johnson & Johnson Company Information
  11.3.2 Johnson & Johnson Long-acting Injectable Medications Product Offered
  11.3.3 Johnson & Johnson Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Johnson & Johnson Main Business Overview
  11.3.5 Johnson & Johnson Latest Developments
11.4 Zogenix
  11.4.1 Zogenix Company Information
  11.4.2 Zogenix Long-acting Injectable Medications Product Offered
  11.4.3 Zogenix Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Zogenix Main Business Overview
  11.4.5 Zogenix Latest Developments
11.5 DURECT
  11.5.1 DURECT Company Information
  11.5.2 DURECT Long-acting Injectable Medications Product Offered
  11.5.3 DURECT Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 DURECT Main Business Overview
  11.5.5 DURECT Latest Developments
11.6 Mapi Pharma
  11.6.1 Mapi Pharma Company Information
  11.6.2 Mapi Pharma Long-acting Injectable Medications Product Offered
  11.6.3 Mapi Pharma Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Mapi Pharma Main Business Overview
  11.6.5 Mapi Pharma Latest Developments
11.7 GSK
  11.7.1 GSK Company Information
  11.7.2 GSK Long-acting Injectable Medications Product Offered
  11.7.3 GSK Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 GSK Main Business Overview
  11.7.5 GSK Latest Developments
11.8 MedinCell
  11.8.1 MedinCell Company Information
  11.8.2 MedinCell Long-acting Injectable Medications Product Offered
  11.8.3 MedinCell Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 MedinCell Main Business Overview
  11.8.5 MedinCell Latest Developments
11.9 Oakwood Labs
  11.9.1 Oakwood Labs Company Information
  11.9.2 Oakwood Labs Long-acting Injectable Medications Product Offered
  11.9.3 Oakwood Labs Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Oakwood Labs Main Business Overview
  11.9.5 Oakwood Labs Latest Developments
11.10 Nanomi
  11.10.1 Nanomi Company Information
  11.10.2 Nanomi Long-acting Injectable Medications Product Offered
  11.10.3 Nanomi Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Nanomi Main Business Overview
  11.10.5 Nanomi Latest Developments
11.11 Pharmathen
  11.11.1 Pharmathen Company Information
  11.11.2 Pharmathen Long-acting Injectable Medications Product Offered
  11.11.3 Pharmathen Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Pharmathen Main Business Overview
  11.11.5 Pharmathen Latest Developments
11.12 Kashiv BioSciences
  11.12.1 Kashiv BioSciences Company Information
  11.12.2 Kashiv BioSciences Long-acting Injectable Medications Product Offered
  11.12.3 Kashiv BioSciences Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Kashiv BioSciences Main Business Overview
  11.12.5 Kashiv BioSciences Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Long-acting Injectable Medications Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Long-acting Injectable Medications Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of First-generation
Table 4. Major Players of Second-generation
Table 5. Long-acting Injectable Medications Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Long-acting Injectable Medications Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Long-acting Injectable Medications Market Size Market Share by Type (2020-2025)
Table 8. Long-acting Injectable Medications Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Long-acting Injectable Medications Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Long-acting Injectable Medications Market Size Market Share by Application (2020-2025)
Table 11. Global Long-acting Injectable Medications Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Long-acting Injectable Medications Revenue Market Share by Player (2020-2025)
Table 13. Long-acting Injectable Medications Key Players Head office and Products Offered
Table 14. Long-acting Injectable Medications Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Long-acting Injectable Medications Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Long-acting Injectable Medications Market Size Market Share by Region (2020-2025)
Table 19. Global Long-acting Injectable Medications Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Long-acting Injectable Medications Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Long-acting Injectable Medications Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Long-acting Injectable Medications Market Size Market Share by Country (2020-2025)
Table 23. Americas Long-acting Injectable Medications Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Long-acting Injectable Medications Market Size Market Share by Type (2020-2025)
Table 25. Americas Long-acting Injectable Medications Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Long-acting Injectable Medications Market Size Market Share by Application (2020-2025)
Table 27. APAC Long-acting Injectable Medications Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Long-acting Injectable Medications Market Size Market Share by Region (2020-2025)
Table 29. APAC Long-acting Injectable Medications Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Long-acting Injectable Medications Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Long-acting Injectable Medications Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Long-acting Injectable Medications Market Size Market Share by Country (2020-2025)
Table 33. Europe Long-acting Injectable Medications Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Long-acting Injectable Medications Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Long-acting Injectable Medications Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Long-acting Injectable Medications Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Long-acting Injectable Medications Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Long-acting Injectable Medications
Table 39. Key Market Challenges & Risks of Long-acting Injectable Medications
Table 40. Key Industry Trends of Long-acting Injectable Medications
Table 41. Global Long-acting Injectable Medications Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Long-acting Injectable Medications Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Long-acting Injectable Medications Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Long-acting Injectable Medications Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Eli Lilly Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 46. Eli Lilly Long-acting Injectable Medications Product Offered
Table 47. Eli Lilly Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Eli Lilly Main Business
Table 49. Eli Lilly Latest Developments
Table 50. Alkermes Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 51. Alkermes Long-acting Injectable Medications Product Offered
Table 52. Alkermes Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Alkermes Main Business
Table 54. Alkermes Latest Developments
Table 55. Johnson & Johnson Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 56. Johnson & Johnson Long-acting Injectable Medications Product Offered
Table 57. Johnson & Johnson Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Johnson & Johnson Main Business
Table 59. Johnson & Johnson Latest Developments
Table 60. Zogenix Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 61. Zogenix Long-acting Injectable Medications Product Offered
Table 62. Zogenix Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Zogenix Main Business
Table 64. Zogenix Latest Developments
Table 65. DURECT Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 66. DURECT Long-acting Injectable Medications Product Offered
Table 67. DURECT Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. DURECT Main Business
Table 69. DURECT Latest Developments
Table 70. Mapi Pharma Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 71. Mapi Pharma Long-acting Injectable Medications Product Offered
Table 72. Mapi Pharma Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Mapi Pharma Main Business
Table 74. Mapi Pharma Latest Developments
Table 75. GSK Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 76. GSK Long-acting Injectable Medications Product Offered
Table 77. GSK Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. GSK Main Business
Table 79. GSK Latest Developments
Table 80. MedinCell Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 81. MedinCell Long-acting Injectable Medications Product Offered
Table 82. MedinCell Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. MedinCell Main Business
Table 84. MedinCell Latest Developments
Table 85. Oakwood Labs Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 86. Oakwood Labs Long-acting Injectable Medications Product Offered
Table 87. Oakwood Labs Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Oakwood Labs Main Business
Table 89. Oakwood Labs Latest Developments
Table 90. Nanomi Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 91. Nanomi Long-acting Injectable Medications Product Offered
Table 92. Nanomi Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Nanomi Main Business
Table 94. Nanomi Latest Developments
Table 95. Pharmathen Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 96. Pharmathen Long-acting Injectable Medications Product Offered
Table 97. Pharmathen Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Pharmathen Main Business
Table 99. Pharmathen Latest Developments
Table 100. Kashiv BioSciences Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors
Table 101. Kashiv BioSciences Long-acting Injectable Medications Product Offered
Table 102. Kashiv BioSciences Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Kashiv BioSciences Main Business
Table 104. Kashiv BioSciences Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Long-acting Injectable Medications Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-acting Injectable Medications Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Long-acting Injectable Medications Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Long-acting Injectable Medications Sales Market Share by Country/Region (2024)
Figure 8. Long-acting Injectable Medications Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Long-acting Injectable Medications Market Size Market Share by Type in 2024
Figure 10. Long-acting Injectable Medications in Schizophrenia
Figure 11. Global Long-acting Injectable Medications Market: Schizophrenia (2020-2025) & ($ millions)
Figure 12. Long-acting Injectable Medications in Contraception
Figure 13. Global Long-acting Injectable Medications Market: Contraception (2020-2025) & ($ millions)
Figure 14. Long-acting Injectable Medications in HIV
Figure 15. Global Long-acting Injectable Medications Market: HIV (2020-2025) & ($ millions)
Figure 16. Long-acting Injectable Medications in Others
Figure 17. Global Long-acting Injectable Medications Market: Others (2020-2025) & ($ millions)
Figure 18. Global Long-acting Injectable Medications Market Size Market Share by Application in 2024
Figure 19. Global Long-acting Injectable Medications Revenue Market Share by Player in 2024
Figure 20. Global Long-acting Injectable Medications Market Size Market Share by Region (2020-2025)
Figure 21. Americas Long-acting Injectable Medications Market Size 2020-2025 ($ millions)
Figure 22. APAC Long-acting Injectable Medications Market Size 2020-2025 ($ millions)
Figure 23. Europe Long-acting Injectable Medications Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Long-acting Injectable Medications Market Size 2020-2025 ($ millions)
Figure 25. Americas Long-acting Injectable Medications Value Market Share by Country in 2024
Figure 26. United States Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Long-acting Injectable Medications Market Size Market Share by Region in 2024
Figure 31. APAC Long-acting Injectable Medications Market Size Market Share by Type (2020-2025)
Figure 32. APAC Long-acting Injectable Medications Market Size Market Share by Application (2020-2025)
Figure 33. China Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 37. India Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Long-acting Injectable Medications Market Size Market Share by Country in 2024
Figure 40. Europe Long-acting Injectable Medications Market Size Market Share by Type (2020-2025)
Figure 41. Europe Long-acting Injectable Medications Market Size Market Share by Application (2020-2025)
Figure 42. Germany Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 43. France Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Long-acting Injectable Medications Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 56. APAC Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 57. Europe Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 59. United States Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 60. Canada Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 61. Mexico Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 62. Brazil Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 63. China Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 64. Japan Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 65. Korea Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 67. India Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 68. Australia Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 69. Germany Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 70. France Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 71. UK Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 72. Italy Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 73. Russia Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 74. Egypt Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 75. South Africa Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 76. Israel Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 77. Turkey Long-acting Injectable Medications Market Size 2026-2031 ($ millions)
Figure 78. Global Long-acting Injectable Medications Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Long-acting Injectable Medications Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Long-acting Injectable Medications Market Size 2026-2031 ($ millions)